Use of Mifepristone along with Misoprostol for medical abortion in second trimester of pregnancy.

To study the safety and efficacy of use of Mifepristone along with Misoprostol for medical termination of pregnancy in second trimester (12-20weeks)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/03/003488

Enrollment

100

Registered

2013-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Women opting for Medical Termination of pregnancy in second trimester(12-20weeks)

Interventions

Intervention1: Mifepristone Misoprostol: All women opting to undergo medical termination of pregnancy(12-20weeks)will receive 200mg of oral Mifepristone along with 400mcg of Misoprostol vaginally foll

Eligibility

Inclusion criteria

Inclusion criteria: Women wanting to undergo second trimester medical termination of pregnancy (12-20weeks)

Exclusion criteria

Exclusion criteria: Known hypersensitivity to Mifepristone or Misoprostol Women with medical renal disease,liver disease Women with heart disease Hb less than 8gm%

Design outcomes

Primary

Measure	Time frame
Safety and efficacy of use of Mifepristone along with Misoprostol for second trimester medical termination of pregnancy(12-20weeks)Timepoint: 12-20weeks	—

Secondary

Measure	Time frame
1)addional intervention required 2)estimation of blood lossTimepoint: 24 hours after last dose of misoprostol	—

Countries

India

Contacts

Public ContactDr Puspa Junghare

Dr Panjabrao Desmukh Memorial Medical College and Research Institute

rupasi2001@yahoo.co.in91-9922914788

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 5, 2026